OPOndřEj Peterka

OndřEj Peterka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


OndřEj Peterka has a total of 40 co-authors. Here are the top co-authors by number of shared publications:

  • Michal Holčapek

    University of Pardubice, Faculty of Chemical Technology, Department of Analytical Chemistry, Pardubice, Czech Republic

    10 shared publications
  • Robert Jirásko

    University of Pardubice, Faculty of Chemical Technology, Department of Analytical Chemistry, Studentská 573, 532 10, Pardubice, Czech Republic

    7 shared publications
  • Anna Taylor

    University of Pardubice, Faculty of Chemical Technology, Department of Analytical Chemistry, Studentská 573, 532 10, Pardubice, Czech Republic

    3 shared publications
  • Robert Jirásko

    University of Pardubice, Faculty of Chemical Technology, Department of Analytical Chemistry, Pardubice, Czech Republic

    3 shared publications
  • Zuzana Lásko

    Department of Analytical Chemistry, Faculty of Chemical Technology, University of Pardubice, Pardubice, Czech Republic

    3 shared publications
  • Anna Taylor

    University of Pardubice, Faculty of Chemical Technology, Department of Analytical Chemistry, Pardubice, Czech Republic

    2 shared publications

Latest Publications

  • RP-UHPLC/MS/MS reveals statin-induced alterations in profiles of free monohydroxy sterols and tocopherols in human plasma

    by Yasmin Kadyrbekova, OndřEj Peterka, Robert Jirásko, Lenka Dubská, Anna Taylor, Michal Holčapek


  • Open Access

    Pilot study of screening method for pancreatic cancer using lipidomic profiling of plasma or serum

    by OndřEj Peterka, Robert Jirásko, Zuzana Dolečková, Mária Dosoudilová, Josef Bártl, Jakub Idkowiak, OndřEj Slavíček, Karolína Pešková, Milan Vošmik, Beatrice Mohelníková-Duchoňová, et al.

    Background Pancreatic cancer is one of the most aggressive malignancies with a 5-year relative survival rate of only 13%. Its poor prognosis is largely attributed to the lack of reliable tools for early detection. Current diagnostic standards rely on imaging methods that are invasive, costly, and often inadequate to detect early-stage disease. A noninvasive blood-based test with high sensitivity and specificity could substantially improve patient outcomes. Methods Lipid concentrations in plasma and serum samples were determined by ultrahigh-performance supercritical fluid chromatography–mass spectrometry, and multivariate statistical modeling was used to analyze lipid profiles and differentiate between groups. Results Here, we present results from a pilot study evaluating lipidomic profiling of prospectively collected plasma and serum samples from patients with pancreatic ductal adenocarcinoma (PDAC, n = 177), healthy controls (n = 218), and high-risk individuals for pancreatic cancer (n = 93). The lipidomic test distinguishes PDAC patients from healthy controls with an accuracy exceeding 95%, including robust detection of early-stage cases and even individuals with low CA 19-9 secretion. The sensitivity is approximately 30% higher than that of CA 19-9. In high-risk individuals, the method achieves a specificity of over 96% (95% CI, 89–99%), comparable to established imaging-based approaches. Conclusions This pilot study demonstrates the promising potential of lipidomic profiling as a noninvasive, blood-based screening tool for pancreatic cancer. The method outperforms current biomarkers, maintains high diagnostic accuracy in early-stage disease, and performs reliably in high-risk populations. These findings support the initiation of a clinical trial aimed at validating the lipidomic test for the early detection of PDAC.


  • Open Access

    Comprehensive lipidomic characterization of human blood by high-throughput UHPSFC/MS using bioinert column and modified MTBE extraction

    by Petra Peroutková, Robert Jirásko, Anna Taylor, Michal Holčapek, OndřEj Peterka


  • Open Access

    Improved preanalytical workflow for pancreatic tissue lipidomics: insights into lipid stability and polar lipid recovery

    by Karol Parchem, Malena Manzi, Robert Jirásko, OndřEj Peterka, Zuzana Lásko, OndřEj Kuda, Michal Holčapek


  • Open Access

    Comprehensive Lipidomic Characterization of Human Blood by High-Throughput UHPSFC/MS using Bioinert Column and Modified MTBE Extraction

    by Petra Peroutková, Robert Jirásko, Anna Taylor, Michal Holčapek, OndřEj Peterka

    Supercritical fluid chromatography is traditionally employed for nonpolar and moderately polar analytes, while the analysis of ionic compounds remains a recognized limitation of the technique. Here, we introduce a novel ultrahigh-performance supercritical fluid chromatography–mass spectrometry (UHPSFC/MS) method using a bioinert column, enabling the separation of lipids with a broad polarity range from nonpolar to ionic species. The UHPSFC/MS method was optimized using 79 lipid species across 41 lipid subclasses, achieving a total run time of 7.5 min, including the column equilibration. The comparison of the separation with conventional and bioinert columns revealed a substantial improvement in peak shapes for ionic lipid classes, such as PS, LPS, PA, LPA, CerP, and SPBP. Additionally, we introduce a combination of the modified chloroform-free extraction followed by a hexane elimination step, which reduces concentrations of nonpolar lipids allowing the injection of more concentrated extracts and minimize ion source contamination. The optimized methodology was applied for the untargeted analysis of human plasma and erythrocyte-rich fraction to achieve highly confident identification of 657 lipid species across 37 lipid subclasses in human blood. The method followed the recommendations for validation of (bio)analytical methods, and its accuracy was confirmed by quantitative analysis of the reference material NIST SRM 1950, with the determined concentrations in agreement with the consensus values from ring trials. The current methodology represents a novel high-throughput and comprehensive quantitative lipidomic method for biological samples. Moreover, the findings provide the potential for the development of bioinert components for SFC platforms.

  • RP-UHPLC/MS/MS provides enhanced lipidomic profiling of human serum in pancreatic cancer

    by Zuzana Lásko, OndřEj Peterka, Robert Jirásko, Anna Taylor, Tomáš Hájek, Beatrice Mohelníková-Duchoňová, Martin Loveček, Bohuslav Melichar, Michal Holčapek


  • Open Access

    Comprehensive Quantitative Profiling of Less Polar Lipids in Human Plasma Using Validated Reversed-Phase UHPSFC/MS/MS

    by Zuzana Lásko, Veronika Šubrtová, Ondřej Peterka, Robert Jirásko, Michal Holčapek

    The quantitative analysis of lipids is challenging due to their structural diversity and the coexistence of numerous isomers in biological samples. Here, we present a robust and validated method based on reversed-phase ultrahigh-performance supercritical fluid chromatography-tandem mass spectrometry (RP-UHPSFC/MS/MS) for the high-throughput profiling of less polar lipids in human plasma. The sample preparation workflow involves an initial Folch-based extraction, followed by chemical derivatization with benzoyl chloride, and the final liquid-liquid extraction into hexane to isolate less polar acylated analytes. This strategy enables the sensitive profiling of six major lipid classes (TG, DG, MG, SE, ST, and FA) in positive ion mode in less than 18 min. The use of two C18 columns in series provides high chromatographic resolution, sufficient to separate isomeric species, including cis/trans and positional isomers of double bonds in fatty acids. The method was rigorously validated for five lipid classes, except free FA, and the implementation of response factors was shown to be essential for the accurate quantification of sterol esters. A total of 147 lipid species were quantified in NIST SRM 1950 human plasma, demonstrating its suitability for large-scale lipidomic studies focused on less polar lipids.


  • Open Access

    RP-UHPLC/MS/MS Provides Enhanced Lipidomic Profiling of Human Serum in Pancreatic Cancer

    by Zuzana Lásko, Ondřej Peterka, Robert Jirásko, Anna Taylor, Tomáš Hájek, Beatrice Mohelníková-Duchoňová, Martin Loveček, Bohuslav Melichar, Michal Holčapek

    Background: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers, mainly due to the late diagnosis and the lack of reliable biomarkers. Lipidomics provides a promising approach for identifying disease-related alterations, but existing methods are often limited to lipid class profiles with insufficient molecular detail. Reversed-phase ultrahigh-performance liquid chromatography coupled to tandem mass spectrometry (RP-UHPLC/MS/MS) offers the possibility to determine lipids at the fatty acyl/alkyl level. Here, we address the need for a validated quantitative workflow that enables accurate and reproducible lipidomic profiling of human serum in the context of PDAC. Results: We developed and validated an RP-UHPLC/MS/MS method using multiple reaction monitoring, enabling identification of 455 lipid species from 22 subclasses and quantitation of 381 species. The workflow included a response factor correction for sterol esters, which markedly improved their quantification accuracy. The application to serum samples from 54 PDAC patients and 55 healthy controls yielded highly reproducible data, with clear group separation observed in both unsupervised and supervised statistical analyses. Dysregulation was most prominent in sphingolipids and phospholipids. Very long-chain saturated sphingolipids (≥ C22) were downregulated, while some shorter or unsaturated chains showed mild upregulation. Phospholipid alterations were dominated by species containing polyunsaturated fatty acyls, particularly 18:2 and 20:4, with plasmalogens showing the strongest changes. These structurally resolved findings were further supported by gas chromatography – mass spectrometry analysis of fatty acid methyl esters. Significance: This validated workflow provides comprehensive quantitative coverage across 22 lipid subclasses with the structural resolution critical for biological interpretation. The detailed mapping of sphingolipid and phospholipid dysregulation in PDAC demonstrates that only the fatty acyl level annotation reveals molecular signatures that may reflect specific enzymatic activities or pathways. The method delivers a robust platform for biomarker discovery and mechanistic studies in cancer lipidomics. HIGHLIGHTS: Validated RP-UHPLC/MS/MS method quantifies 381 lipid species from 22 subclasses. Response factors improve the accuracy of sterol ester quantification. Lipidomic data enables clear discrimination of cancer and control groups. Molecular species resolution reveals hidden lipidomic alterations. Sphingolipid dysregulation is mainly determined by N -acyl chain composition. GRAPHICAL


  • Open Access

    Bioinert UHPLC system improves sensitivity and peak shapes for ionic metabolites

    by Ondřej Peterka, Alena Langová, Robert Jirásko, Michal Holčapek


  • HILIC/MS quantitation of low-abundant phospholipids and sphingolipids in human plasma and serum: Dysregulation in pancreatic cancer

    by Ondřej Peterka, Alessandro Maccelli, Robert Jirásko, Zuzana Vaňková, Jakub Idkowiak, Roman Hrstka, Denise Wolrab, Michal Holčapek